Meditation Apps for Stress Management in Black Women
Feasibility, Acceptability, and Preliminary Effects of Culturally-Adapted and Generic Meditation Apps for Stress Reduction in Middle-Aged Black Women
This randomized remote pilot study will evaluate the feasibility, acceptability, and preliminary effects of two meditation and mindfulness applications among approximately 40 Black women ages 35-64 experiencing moderate to high stress.
Participants will be randomly assigned in a 1:1 ratio to Exhale™, a culturally adapted meditation app designed for Black women, or Levelhead, a general mindfulness app. Participants will be asked to complete at least one session using their assigned app per day, lasting approximately 5 minutes or longer, at least 5 days per week for 4 weeks.
Participants will complete online questionnaires at baseline and after the 4-week intervention. Daily Remind messages and weekly study check-ins will support engagement. Outcomes include recruitment, retention, adherence, assessment completion, satisfaction, usability, perceived stress, race-based stress, sleep, depression, anxiety, cultural relevance, and brief participant feedback.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This study is a two-arm, randomized, fully remote pilot study comparing Exhale™, a culturally adapted meditation application designed for Black women, with Levelhead, a general science-based mindfulness application.
Approximately 40 Black women ages 35-64 who report moderate to high perceived stress will be enrolled. After eligibility screening, informed consent, and completion of baseline questionnaires through REDCap, participants will be randomized in a 1:1 ratio to Exhale™ or Levelhead using the REDCap randomization module.
Participants in both groups will be asked to complete at least one app-based meditation or mindfulness session per day, lasting approximately 5 minutes or longer, at least 5 days per week for 4 weeks. Participants may complete additional or longer sessions but will not be required to make up missed sessions. Daily Remind messages will ask participants whether they completed a session and the approximate number of minutes practiced. Weekly check-ins will provide study reminders and opportunities to request technical assistance.
Remote questionnaires will be administered at baseline and at the end of Week 4. Primary outcomes will assess feasibility and acceptability through recruitment, retention, adherence, assessment completion, satisfaction, and usability. Secondary outcomes will examine preliminary changes in perceived stress, race-based stress, sleep, depression, and anxiety. Cultural relevance and brief open-ended participant feedback will also be collected. Some participants may be invited to complete an optional brief remote exit interview.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Sunny Kim, PhD
- Telefoonnummer: 602-496-6789
- E-mail: sunny.kim@asu.edu
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Self-identifies as a Black or African American woman
- Ages 35-64 years
- Able to read and speak English
- Perceived Stress Scale-10 screening score greater than 14
- Has access to a smartphone or tablet with internet access
- Willing to complete remote baseline and post-intervention assessments
- Willing to attempt the assigned app-based practice for 4 weeks
- Willing to receive study communications
Exclusion Criteria:
- Regular use of meditation or mindfulness applications within the previous 6 months
- Any prior use of Exhale™
- Significant hearing impairment that prevents engagement with audio-based application content
- Self-reported difficulty navigating smartphone applications that would prevent participation
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Exhale™ Meditation App
Participants assigned to Exhale™ will use a culturally adapted meditation application designed for Black women.
Participants will be asked to complete at least one meditation session per day, lasting approximately 5 minutes or longer, at least 5 days per week for 4 weeks.
Participants will receive daily Remind messages, weekly study check-ins, and remote technical support as needed.
|
A culturally adapted meditation application designed for Black women that provides guided meditation and mindfulness content addressing stress, rest, grounding, self-care, and culturally relevant experiences.
Participants will manually select sessions and complete approximately 5 minutes or longer of practice at least 5 days per week for 4 weeks.
|
|
Actieve vergelijker: Levelhead Mindfulness App
Participants assigned to Levelhead will use a general science-based mindfulness application.
Participants will be asked to complete at least one mindfulness session per day, totaling approximately 5 minutes or longer, at least 5 days per week for 4 weeks.
Participants will receive daily Remind messages, weekly study check-ins, and remote technical support as needed.
|
A general science-based mindfulness application that provides brief lessons addressing topics such as stress, focus, gratitude, and well-being.
Participants will complete approximately 5 minutes or longer of mindfulness practice at least 5 days per week for 4 weeks.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Participant Retention Rate at Week 4
Tijdsspanne: Baseline through Week 4
|
Percentage of enrolled participants who complete the 4-week intervention and post-intervention assessment.
The feasibility benchmark is greater than 75%.
|
Baseline through Week 4
|
|
Percentage of Eligible Individuals Who Consent and Enroll
Tijdsspanne: From recruitment opening through enrollment of the final participant, up to 6 months.
|
Recruitment rate will equal the number of eligible individuals who consent and enroll divided by the total number determined eligible, multiplied by 100.
The feasibility benchmark is greater than 70%.
|
From recruitment opening through enrollment of the final participant, up to 6 months.
|
|
Percentage of Recommended Practice Days Completed
Tijdsspanne: During the 4-week intervention
|
Adherence will be calculated from participant self-reports as completed practice days divided by 20 recommended practice days, multiplied by 100.
The benchmark is greater than 75%.
|
During the 4-week intervention
|
|
Assessment Completion Rate
Tijdsspanne: Baseline and Week 4
|
Percentage of expected baseline and post-intervention questionnaires completed by enrolled participants.
The benchmark is greater than 75%.
|
Baseline and Week 4
|
|
Participant Satisfaction With Assigned App
Tijdsspanne: Week 4
|
Satisfaction will be measured with the assigned-app satisfaction questionnaire.
Items are rated from 1 to 5, with higher scores indicating greater satisfaction.
Results will be summarized overall and by intervention arm.
|
Week 4
|
|
Assigned-App Usability Measured by the System Usability Scale
Tijdsspanne: Week 4
|
The 10-item System Usability Scale produces a total score from 0 to 100.
Higher scores indicate better perceived usability.
|
Week 4
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Perceived Stress Scale-10 Score
Tijdsspanne: Baseline to Week 4
|
The PSS-10 contains 10 items and produces a total score from 0 to 40.
Higher scores indicate greater perceived stress.
Change from baseline will be reported overall and by arm.
|
Baseline to Week 4
|
|
Change in Index of Race-Related Stress-Brief Score
Tijdsspanne: Baseline to Week 4
|
The 22-item IRRS-B produces a total score from 0 to 88.
Higher scores indicate greater race-related stress.
Change from baseline will be reported overall and by arm.
|
Baseline to Week 4
|
|
Change in POMS-SF Depression Subscale Score
Tijdsspanne: Baseline to Week 4
|
The six-item depression subscale produces a score from 0 to 24.
Higher scores indicate greater depressive mood disturbance.
|
Baseline to Week 4
|
|
Change in POMS-SF Tension/Anxiety Subscale Score
Tijdsspanne: Baseline to Week 4
|
The six-item tension/anxiety subscale produces a score from 0 to 24.
Higher scores indicate greater tension or anxiety.
|
Baseline to Week 4
|
|
Change in Insomnia Severity Index Score
Tijdsspanne: Baseline to Week 4
|
The seven-item Insomnia Severity Index produces a total score from 0 to 28.
Higher scores indicate more severe insomnia symptoms.
|
Baseline to Week 4
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Participant-Reported Cultural Relevance and App Feedback
Tijdsspanne: Week 4 and, when applicable, within approximately 1 week after Week 4
|
Cultural relevance, perceived usefulness, barriers, benefits, and recommendations will be assessed through post-intervention items and brief open-ended feedback.
Optional remote interviews may provide additional qualitative feedback.
|
Week 4 and, when applicable, within approximately 1 week after Week 4
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- STUDY00023706
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .